Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Connick

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
The Journal of Infectious Diseases|December 23, 1999
Rapid accumulation of human immunodeficiency virus (HIV) in lymphatic tissue reservoirs during acute and early HIV infection: implications for timing of antiretroviral therapyT Schacker, S Little, E Connick, et al.
Clinical and Diagnostic Laboratory Immunology|September 6, 2000
Shipment impairs lymphocyte proliferative responses to microbial antigensR A Betensky, E Connick, J Devers, et al.
Blood|May 9, 2001
A potential role for interleukin-7 in T-cell homeostasisT J Fry, E Connick, J Falloon, et al.
The Journal of Infectious Diseases|February 15, 2001
Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infectionT Schacker, S Little, E Connick, et al.
The Journal of Clinical Investigation|July 3, 1998
In vivo analysis of Fas/FasL interactions in HIV-infected patientsA D Badley, D H Dockrell, A Algeciras, et al.
The Journal of Infectious Diseases|December 26, 2001
Relationship between human immunodeficiency virus type 1 (HIV-1)-specific memory cytotoxic T lymphocytes and virus load after recent HIV-1 seroconversionE Connick, R L Schlichtemeier, M B Purner, et al.
The Journal of Infectious Diseases|March 9, 1999
Characterization of viral dynamics in human immunodeficiency virus type 1-infected patients treated with combination antiretroviral therapy: relationships to host factors, cellular restoration, and virologic end pointsH Wu, D R Kuritzkes, D R McClernon, et al.
AIDS (London, England)|March 14, 2000
Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen. ACTG 375 team. AIDS Clinical Trials GroupH Valdez, K Y Smith, A Landay, et al.
Blood|July 27, 2000
Prolonged survival and tissue trafficking following adoptive transfer of CD4zeta gene-modified autologous CD4(+) and CD8(+) T cells in human immunodeficiency virus-infected subjectsR T Mitsuyasu, P A Anton, S G Deeks, et al.
The Journal of Infectious Diseases|July 4, 1998
Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315M M Lederman, E Connick, A Landay, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
The Journal of Infectious Diseases|December 23, 1999
Rapid accumulation of human immunodeficiency virus (HIV) in lymphatic tissue reservoirs during acute and early HIV infection: implications for timing of antiretroviral therapyT Schacker, S Little, E Connick, et al.
Clinical and Diagnostic Laboratory Immunology|September 6, 2000
Shipment impairs lymphocyte proliferative responses to microbial antigensR A Betensky, E Connick, J Devers, et al.
Blood|May 9, 2001
A potential role for interleukin-7 in T-cell homeostasisT J Fry, E Connick, J Falloon, et al.
The Journal of Infectious Diseases|February 15, 2001
Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infectionT Schacker, S Little, E Connick, et al.
The Journal of Clinical Investigation|July 3, 1998
In vivo analysis of Fas/FasL interactions in HIV-infected patientsA D Badley, D H Dockrell, A Algeciras, et al.
The Journal of Infectious Diseases|December 26, 2001
Relationship between human immunodeficiency virus type 1 (HIV-1)-specific memory cytotoxic T lymphocytes and virus load after recent HIV-1 seroconversionE Connick, R L Schlichtemeier, M B Purner, et al.
The Journal of Infectious Diseases|March 9, 1999
Characterization of viral dynamics in human immunodeficiency virus type 1-infected patients treated with combination antiretroviral therapy: relationships to host factors, cellular restoration, and virologic end pointsH Wu, D R Kuritzkes, D R McClernon, et al.
AIDS (London, England)|March 14, 2000
Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen. ACTG 375 team. AIDS Clinical Trials GroupH Valdez, K Y Smith, A Landay, et al.
Blood|July 27, 2000
Prolonged survival and tissue trafficking following adoptive transfer of CD4zeta gene-modified autologous CD4(+) and CD8(+) T cells in human immunodeficiency virus-infected subjectsR T Mitsuyasu, P A Anton, S G Deeks, et al.
The Journal of Infectious Diseases|July 4, 1998
Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315M M Lederman, E Connick, A Landay, et al.
Pageof 4